Bioluminescence Researcher Dies

Harvard biochemist J. Woodland Hastings, who first theorized about quorum sensing in the late 1960s, succumbed to pulmonary fibrosis last week at age 87.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NIH, TINSLEY DAVISJ. Woodland “Woody” Hastings, whose work on the luminescent marine bacterium Vibrio fischeri led to the characterization of quorum sensing, died last week (August 6) in his home in Lexington, Massachusetts. The cause was pulmonary fibrosis, according to his family; he was 87.

When Hastings and his colleague Kenneth Nealson first uncovered evidence in the late 1960s that V. fischeri could communicate with one another, only producing the bioluminescence once their population reached certain concentrations, the scientific community was skeptical. In fact, quorum sensing, as it came to be known, was not accepted until nearly 20 years later, when researchers identified the molecule that allowed the bacteria to sense the concentration of their community. And it was another decade before quorum sensing was recognized as a widespread bacterial phenomenon.

“One of Woody’s great fortes was coming up with concepts,” Nealson, an environmental science professor at the University of Southern California, told The New York Times. “He would see things other people wouldn’t see.”

Hastings began his work on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio